Leading the Wave in Indonesia: PSK Debuts Cutting-Edge Tech at ASMIHA 2025
From October 1 to 4, 2025, the Annual Scientific Meeting of the Indonesian Heart Association (ASMIHA 2025) – Indonesia’s annual flagship event in cardiology – was grandly held in Jakarta. Aimed at fostering in-depth exchanges among professionals in the cardiovascular field, the conference featured a comprehensive agenda covering scientific sessions, thematic seminars, cultural evenings and various social activities. It was also honored to have the participation of many internationally renowned authoritative societies, including the American Heart Association (AHA), the Asian Society of Cardiovascular Imaging (ASCI), the Asia Pacific Society of Cardiology (APSC) and the American College of Cardiology (ACC), making it an unprecedentedly grand gathering.
Representing PSK and its U.S. strategic partner Vasomedical, PSK Indonesia Branch actively took part in this top-tier industry event. It showcased its innovative solutions in the field of cardiac rehabilitation to cardiologists from around the world, garnering widespread attention and acclaim from the attendees.
Expert Leadership: Sharing Chinese Experience and Models
During the conference, two distinguished Chinese cardiologists – Professor Meng Xiaoping and Dr. Leng Xiuyu – were invited to deliver keynote speeches. Dr. Leng Xiuyu systematically introduced the mature application and outstanding clinical outcomes of Enhanced External Counterpulsation (EECP) technology in China, highlighting its pivotal role in the treatment of cardiovascular diseases. Professor Meng Xiaoping, on the other hand, elaborated in depth on the innovative “5+1 Prescription Model for Cardiac Rehabilitation”, providing valuable and replicable practical experience for the integrated management of cardiac rehabilitation in regions outside China, especially in the Southeast Asian market.
Professor Meng Xiaoping also served as the chair of a symposium on the comprehensive treatment of hypertension and chronic coronary syndrome during the conference, conducting in-depth discussions with the participating experts.
Live Technology Demonstration: Igniting a Frenzy of Interaction at the Seminar
At the highly anticipated EECP thematic seminar, the PSK team conducted a live operation demonstration of the EECP treatment device for on-site physicians, intuitively showcasing the device’s performance and treatment procedures. Meanwhile, partner Vasomedical exhibited its latest MCT Electrocardiogram Monitoring System, demonstrating the strong technical integration capabilities of both parties. The demonstration session was marked by a lively atmosphere and enthusiastic interactions. Attending physicians engaged in in-depth and constructive technical discussions with on-site representatives on topics such as the technical principles, clinical indications and operational details of the devices.
Booming Exhibition Booth: Evoking Strong Market Interest
Throughout the conference, the joint exhibition booth of PSK and Vasomedical attracted a continuous stream of visitors. Numerous physicians, scholars and industry professionals from Indonesia and across the globe stopped by to communicate. Booth representatives conducted extensive, proactive and fruitful discussions with visiting guests on EECP technology, cardiac rehabilitation equipment and their integrated solutions. On-site feedback indicated that the market has shown strong interest and robust cooperation intentions in these highly efficient and innovative technologies and devices.
The successful participation in ASMIHA 2025 has not only significantly elevated the brand awareness and influence of PSK in the cardiovascular sector across Southeast Asia, but also further strengthened its connections with top global experts and partners. PSK Indonesia Branch stated that it will continue to be committed to introducing cutting-edge cardiac rehabilitation technologies and concepts to the Indonesian and Asia-Pacific markets, making sustained contributions to improving regional cardiovascular health standards.